Furthermore, in vivo animal experiments confirmed that TGF-β1 can promote stemness characteristics and chemotherapy resistance in ESCC via the TGFR1-Smad2/3 pathway. The gene discussed is SMAD2; the disease is esophageal squamous cell carcinoma.